119 related articles for article (PubMed ID: 38354085)
1. Inflammatory dendritic cells restrain CD11b
Lin M; Chen D; Shao Z; Liu Q; Hao Z; Xin Z; Chen Y; Wu W; Chen X; He T; Wu D; Wu P
Cell Rep; 2024 Feb; 43(2):113767. PubMed ID: 38354085
[TBL] [Abstract][Full Text] [Related]
2. CD200
Wang X; Zha H; Wu W; Yuan T; Xie S; Jin Z; Long H; Yang F; Wang Z; Zhang A; Gao J; Jiang Y; Wang L; Hu C; Wan YY; Li QJ; Symonds ALJ; Jia Q; Zhu B
Sci Transl Med; 2023 Jan; 15(679):eabn5029. PubMed ID: 36652534
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
4. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
Liu JQ; Talebian F; Wu L; Liu Z; Li MS; Wu L; Zhu J; Markowitz J; Carson WE; Basu S; Bai XF
J Immunol; 2016 Aug; 197(4):1489-97. PubMed ID: 27385779
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific cytotoxic T lymphocytes target airway CD103+ and CD11b+ dendritic cells to suppress allergic inflammation.
Daniels NJ; Hyde E; Ghosh S; Seo K; Price KM; Hoshino K; Kaisho T; Okada T; Ronchese F
Mucosal Immunol; 2016 Jan; 9(1):229-39. PubMed ID: 26104914
[TBL] [Abstract][Full Text] [Related]
7. CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.
Liu JQ; Hu A; Zhu J; Yu J; Talebian F; Bai XF
Adv Exp Med Biol; 2020; 1223():155-165. PubMed ID: 32030689
[TBL] [Abstract][Full Text] [Related]
8. Myeloid and lymphoid dendritic cells and cytotoxic T lymphocytes in peripheral blood of non-small cell lung cancer patient--a pilot study.
Krawczyk P; Wojas K; Milanowski P; Roliński J
Adv Med Sci; 2006; 51():160-3. PubMed ID: 17357299
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
[TBL] [Abstract][Full Text] [Related]
10. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
11. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL
Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
[TBL] [Abstract][Full Text] [Related]
12. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T
Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
Su Y; Yamazaki S; Morisue R; Suzuki J; Yoshikawa T; Nakatsura T; Tsuboi M; Ochiai A; Ishii G
Pathobiology; 2021; 88(3):218-227. PubMed ID: 33321503
[TBL] [Abstract][Full Text] [Related]
14. Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.
Talebian F; Liu JQ; Liu Z; Khattabi M; He Y; Ganju R; Bai XF
PLoS One; 2012; 7(2):e31442. PubMed ID: 22319630
[TBL] [Abstract][Full Text] [Related]
15. CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.
Rygiel TP; Karnam G; Goverse G; van der Marel AP; Greuter MJ; van Schaarenburg RA; Visser WF; Brenkman AB; Molenaar R; Hoek RM; Mebius RE; Meyaard L
Oncogene; 2012 Jun; 31(24):2979-88. PubMed ID: 22020332
[TBL] [Abstract][Full Text] [Related]
16. Role of CD200/CD200R Signaling Pathway in Regulation of CD4+T Cell Subsets During Thermal Ablation of Hepatocellular Carcinoma.
Huang S; Pan Y; Zhang Q; Sun W
Med Sci Monit; 2019 Mar; 25():1718-1728. PubMed ID: 30838977
[TBL] [Abstract][Full Text] [Related]
17. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R.
Gorczynski RM; Chen Z; Kai Y; Wong S; Lee L
Transplantation; 2004 Apr; 77(8):1138-44. PubMed ID: 15114074
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer.
Vathiotis IA; MacNeil T; Zugazagoitia J; Syrigos KN; Aung TN; Gruver AM; Vaillancourt P; Hughes I; Hinton S; Driscoll K; Rimm DL
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33804482
[TBL] [Abstract][Full Text] [Related]
19. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
20. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
